Elimination of ~$10bn contractual payments
Company: Core Scientific
The claim, verbatim
The combination eliminates approximately $10 billion in contractual payments and lowers debt financing costs.
Source (primary)
core-scientific 8-K exhibit (ef20057150_ex99-1.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-28)Live source ↗
Quote: “the elimination of ~$10bn in contractual payments and lower debt financing costs associated with the combined company”
How we checked this
Checked on September 30, 2026. The cited source supports every part of this claim.
The deck lists the elimination of ~$10bn in contractual payments and lower debt financing costs as benefits of the combined company. It presents these under potential pro forma combination benefits.
Confirmed in the source:
- The combination eliminates approximately $10 billion in contractual payments
- The combination is associated with lower debt financing costs
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000114036125038207/ef20057150_ex99-1.htm) in full (42,945 characters, retrieved September 28, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (ef20057150_ex99-1.htm)
Quote: “the elimination of ~$10bn in contractual payments and lower debt financing costs associated with the combined company”